MT-2 (Melanotan II) is engineered as a synthetic, cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone ($\alpha$-MSH), acting as a non-selective melanocortin receptor agonist (targeting MC1R, MC3R, MC4R, and MC5R) to facilitate specialized dermatological and central neuro-signaling research.
MC1R Agonism & Melanogenesis Activation: Binds directly to melanocortin-1 receptors on dermal melanocytes to stimulate eumelanin synthesis, optimizing investigation into photoprotective pathways and skin pigmentation dynamics.
Central MC3R/MC4R Pathways: Agonizes central nervous system melanocortin receptors to modulate energy homeostasis, appetite suppression signals, and neuro-sexual behavior pathways.
While endogenous $\alpha$-MSH undergoes rapid enzymatic breakdown, MT-2’s cyclic lactam structure confers high resistance to enzymatic cleavage and significantly extended biological stability—allowing researchers to investigate sustained melanogenesis, central receptor binding, and metabolic signaling without rapid clearance.
Disclaimer: This product is sold strictly for research purposes only. Not for human consumption, clinical trials, or therapeutic use.